 | • レポートコード：GIR-107A14341 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、20sプロテアソームのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。20sプロテアソームの種類別市場規模（マリゾミブ、オプロゾミブ、カーフィルゾミブ、VPEA-002、その他）、用途別市場規模（結腸がん、リンパ腫、悪性神経膠腫、神経内分泌がん、卵巣がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・20sプロテアソームの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen Inc、Celgene Corp ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：マリゾミブ、オプロゾミブ、カーフィルゾミブ、VPEA-002、その他 ・用途別分析2016年-2026年：結腸がん、リンパ腫、悪性神経膠腫、神経内分泌がん、卵巣がん、その他 ・20sプロテアソームの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・20sプロテアソームのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・20sプロテアソームのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・20sプロテアソームの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・20sプロテアソームの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The 20s Proteasome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global 20s Proteasome size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global 20s Proteasome market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
20s Proteasome market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Marizomib
Oprozomib
Carfilzomib
VPEA-002
Others
Market segment by Application can be divided into
Colon Cancer
Lymphoma
Malignant Glioma
Neuroendocrine Cancer
Ovarian Cancer
Others
The key market players for global 20s Proteasome market are listed below:
Amgen Inc
Celgene Corp
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe 20s Proteasome product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of 20s Proteasome, with price, sales, revenue and global market share of 20s Proteasome from 2019 to 2021.
Chapter 3, the 20s Proteasome competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 20s Proteasome breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and 20s Proteasome market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe 20s Proteasome sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 20s Proteasome Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global 20s Proteasome Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Marizomib
1.2.3 Oprozomib
1.2.4 Carfilzomib
1.2.5 VPEA-002
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global 20s Proteasome Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Colon Cancer
1.3.3 Lymphoma
1.3.4 Malignant Glioma
1.3.5 Neuroendocrine Cancer
1.3.6 Ovarian Cancer
1.3.7 Others
1.4 Global 20s Proteasome Market Size & Forecast
1.4.1 Global 20s Proteasome Sales in Value (2016-2026))
1.4.2 Global 20s Proteasome Sales in Volume (2016-2026)
1.4.3 Global 20s Proteasome Price by Type (2016-2026) & (USD/Pcs)
1.5 Global 20s Proteasome Production Capacity Analysis
1.5.1 Global 20s Proteasome Total Production Capacity (2016-2026)
1.5.2 Global 20s Proteasome Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 20s Proteasome Market Drivers
1.6.2 20s Proteasome Market Restraints
1.6.3 20s Proteasome Trends Analysis
2 Manufacturers Profiles
2.1 Amgen Inc
2.1.1 Amgen Inc Details
2.1.2 Amgen Inc Major Business
2.1.3 Amgen Inc 20s Proteasome Product and Services
2.1.4 Amgen Inc 20s Proteasome Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Celgene Corp
2.2.1 Celgene Corp Details
2.2.2 Celgene Corp Major Business
2.2.3 Celgene Corp 20s Proteasome Product and Services
2.2.4 Celgene Corp 20s Proteasome Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 20s Proteasome Sales by Manufacturer
3.1 Global 20s Proteasome Sales in Volume by Manufacturer (2019-2021e)
3.2 Global 20s Proteasome Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in 20s Proteasome
3.4 Market Concentration Rate
3.4.1 Top 3 20s Proteasome Manufacturer Market Share
3.4.2 Top 6 20s Proteasome Manufacturer Market Share
3.5 Global 20s Proteasome Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and 20s Proteasome Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global 20s Proteasome Market Size by Region
4.1.1 Global 20s Proteasome Sales in Volume by Region (2016-2026)
4.1.2 Global 20s Proteasome Revenue by Region (2016-2026)
4.2 North America 20s Proteasome Revenue (2016-2026)
4.3 Europe 20s Proteasome Revenue (2016-2026)
4.4 Asia-Pacific 20s Proteasome Revenue (2016-2026)
4.5 South America 20s Proteasome Revenue (2016-2026)
4.6 Middle East and Africa 20s Proteasome Revenue (2016-2026)
5 Market Segment by Type
5.1 Global 20s Proteasome Sales in Volume by Type (2016-2026)
5.2 Global 20s Proteasome Revenue by Type (2016-2026)
5.3 Global 20s Proteasome Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global 20s Proteasome Sales in Volume by Application (2016-2026)
6.2 Global 20s Proteasome Revenue by Application (2016-2026)
6.3 Global 20s Proteasome Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America 20s Proteasome Sales by Type (2016-2026)
7.2 North America 20s Proteasome Sales by Application (2016-2026)
7.3 North America 20s Proteasome Market Size by Country
7.3.1 North America 20s Proteasome Sales in Volume by Country (2016-2026)
7.3.2 North America 20s Proteasome Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe 20s Proteasome Sales by Type (2016-2026)
8.2 Europe 20s Proteasome Sales by Application (2016-2026)
8.3 Europe 20s Proteasome Market Size by Country
8.3.1 Europe 20s Proteasome Sales in Volume by Country (2016-2026)
8.3.2 Europe 20s Proteasome Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific 20s Proteasome Sales by Type (2016-2026)
9.2 Asia-Pacific 20s Proteasome Sales by Application (2016-2026)
9.3 Asia-Pacific 20s Proteasome Market Size by Region
9.3.1 Asia-Pacific 20s Proteasome Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific 20s Proteasome Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America 20s Proteasome Sales by Type (2016-2026)
10.2 South America 20s Proteasome Sales by Application (2016-2026)
10.3 South America 20s Proteasome Market Size by Country
10.3.1 South America 20s Proteasome Sales in Volume by Country (2016-2026)
10.3.2 South America 20s Proteasome Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa 20s Proteasome Sales by Type (2016-2026)
11.2 Middle East & Africa 20s Proteasome Sales by Application (2016-2026)
11.3 Middle East & Africa 20s Proteasome Market Size by Country
11.3.1 Middle East & Africa 20s Proteasome Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa 20s Proteasome Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 20s Proteasome Typical Distributors
12.3 20s Proteasome Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global 20s Proteasome Revenue by Type, (USD Million), 2021-2026
Table 2. Global 20s Proteasome Revenue by Application, (USD Million), 2021-2026
Table 3. Amgen Inc Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Inc Major Business
Table 5. Amgen Inc 20s Proteasome Product and Services
Table 6. Amgen Inc 20s Proteasome Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Celgene Corp Basic Information, Manufacturing Base and Competitors
Table 8. Celgene Corp Major Business
Table 9. Celgene Corp 20s Proteasome Product and Services
Table 10. Celgene Corp 20s Proteasome Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Global 20s Proteasome Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 12. Global 20s Proteasome Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 13. Market Position of Manufacturers in 20s Proteasome, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 14. Global 20s Proteasome Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 15. Head Office and 20s Proteasome Production Site of Key Manufacturer
Table 16. 20s Proteasome New Entrant and Capacity Expansion Plans
Table 17. 20s Proteasome Mergers & Acquisitions in the Past Five Years
Table 18. Global 20s Proteasome Sales by Region (2016-2021e) & (K Pcs)
Table 19. Global 20s Proteasome Sales by Region (2021-2026) & (K Pcs)
Table 20. Global 20s Proteasome Revenue by Region (2016-2021e) & (USD Million)
Table 21. Global 20s Proteasome Revenue by Region (2021-2026) & (USD Million)
Table 22. Global 20s Proteasome Sales by Type (2016-2021e) & (K Pcs)
Table 23. Global 20s Proteasome Sales by Type (2021-2026) & (K Pcs)
Table 24. Global 20s Proteasome Revenue by Type (2016-2021e) & (USD Million)
Table 25. Global 20s Proteasome Revenue by Type (2021-2026) & (USD Million)
Table 26. Global 20s Proteasome Price by Type (2016-2021e) & (USD/Pcs)
Table 27. Global 20s Proteasome Price by Type (2021-2026) & (USD/Pcs)
Table 28. Global 20s Proteasome Sales by Application (2016-2021e) & (K Pcs)
Table 29. Global 20s Proteasome Sales by Application (2021-2026) & (K Pcs)
Table 30. Global 20s Proteasome Revenue by Application (2016-2021e) & (USD Million)
Table 31. Global 20s Proteasome Revenue by Application (2021-2026) & (USD Million)
Table 32. Global 20s Proteasome Price by Application (2016-2021e) & (USD/Pcs)
Table 33. Global 20s Proteasome Price by Application (2021-2026) & (USD/Pcs)
Table 34. North America 20s Proteasome Sales by Country (2016-2021e) & (K Pcs)
Table 35. North America 20s Proteasome Sales by Country (2021-2026) & (K Pcs)
Table 36. North America 20s Proteasome Revenue by Country (2016-2021e) & (USD Million)
Table 37. North America 20s Proteasome Revenue by Country (2021-2026) & (USD Million)
Table 38. North America 20s Proteasome Sales by Type (2016-2021e) & (K Pcs)
Table 39. North America 20s Proteasome Sales by Type (2021-2026) & (K Pcs)
Table 40. North America 20s Proteasome Sales by Application (2016-2021e) & (K Pcs)
Table 41. North America 20s Proteasome Sales by Application (2021-2026) & (K Pcs)
Table 42. Europe 20s Proteasome Sales by Country (2016-2021e) & (K Pcs)
Table 43. Europe 20s Proteasome Sales by Country (2021-2026) & (K Pcs)
Table 44. Europe 20s Proteasome Revenue by Country (2016-2021e) & (USD Million)
Table 45. Europe 20s Proteasome Revenue by Country (2021-2026) & (USD Million)
Table 46. Europe 20s Proteasome Sales by Type (2016-2021e) & (K Pcs)
Table 47. Europe 20s Proteasome Sales by Type (2021-2026) & (K Pcs)
Table 48. Europe 20s Proteasome Sales by Application (2016-2021e) & (K Pcs)
Table 49. Europe 20s Proteasome Sales by Application (2021-2026) & (K Pcs)
Table 50. Asia-Pacific 20s Proteasome Sales by Region (2016-2021e) & (K Pcs)
Table 51. Asia-Pacific 20s Proteasome Sales by Region (2021-2026) & (K Pcs)
Table 52. Asia-Pacific 20s Proteasome Revenue by Region (2016-2021e) & (USD Million)
Table 53. Asia-Pacific 20s Proteasome Revenue by Region (2021-2026) & (USD Million)
Table 54. Asia-Pacific 20s Proteasome Sales by Type (2016-2021e) & (K Pcs)
Table 55. Asia-Pacific 20s Proteasome Sales by Type (2021-2026) & (K Pcs)
Table 56. Asia-Pacific 20s Proteasome Sales by Application (2016-2021e) & (K Pcs)
Table 57. Asia-Pacific 20s Proteasome Sales by Application (2021-2026) & (K Pcs)
Table 58. South America 20s Proteasome Sales by Country (2016-2021e) & (K Pcs)
Table 59. South America 20s Proteasome Sales by Country (2021-2026) & (K Pcs)
Table 60. South America 20s Proteasome Revenue by Country (2016-2021e) & (USD Million)
Table 61. South America 20s Proteasome Revenue by Country (2021-2026) & (USD Million)
Table 62. South America 20s Proteasome Sales by Type (2016-2021e) & (K Pcs)
Table 63. South America 20s Proteasome Sales by Type (2021-2026) & (K Pcs)
Table 64. South America 20s Proteasome Sales by Application (2016-2021e) & (K Pcs)
Table 65. South America 20s Proteasome Sales by Application (2021-2026) & (K Pcs)
Table 66. Middle East & Africa 20s Proteasome Sales by Country (2016-2021e) & (K Pcs)
Table 67. Middle East & Africa 20s Proteasome Sales by Country (2021-2026) & (K Pcs)
Table 68. Middle East & Africa 20s Proteasome Revenue by Country (2016-2021e) & (USD Million)
Table 69. Middle East & Africa 20s Proteasome Revenue by Country (2021-2026) & (USD Million)
Table 70. Middle East & Africa 20s Proteasome Sales by Type (2016-2021e) & (K Pcs)
Table 71. Middle East & Africa 20s Proteasome Sales by Type (2021-2026) & (K Pcs)
Table 72. Middle East & Africa 20s Proteasome Sales by Application (2016-2021e) & (K Pcs)
Table 73. Middle East & Africa 20s Proteasome Sales by Application (2021-2026) & (K Pcs)
Table 74. Direct Channel Pros & Cons
Table 75. Indirect Channel Pros & Cons
Table 76. 20s Proteasome Typical Distributors
Table 77. 20s Proteasome Typical Customers
List of Figures
Figure 1. 20s Proteasome Picture
Figure 2. Global 20s Proteasome Sales Market Share by Type in 2020
Figure 3. Marizomib
Figure 4. Oprozomib
Figure 5. Carfilzomib
Figure 6. VPEA-002
Figure 7. Others
Figure 8. Global 20s Proteasome Sales Market Share by Application in 2020
Figure 9. Colon Cancer
Figure 10. Lymphoma
Figure 11. Malignant Glioma
Figure 12. Neuroendocrine Cancer
Figure 13. Ovarian Cancer
Figure 14. Others
Figure 15. Global 20s Proteasome Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 16. Global 20s Proteasome Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. Global 20s Proteasome Sales (2016-2026) & (K Pcs)
Figure 18. Global 20s Proteasome Price by Type (2016-2026) & (USD/Pcs)
Figure 19. Global 20s Proteasome Production Capacity (2016-2026) & (K Pcs)
Figure 20. Global 20s Proteasome Production Capacity by Geographic Region: 2020 VS 2021
Figure 21. 20s Proteasome Market Drivers
Figure 22. 20s Proteasome Market Restraints
Figure 23. 20s Proteasome Market Trends
Figure 24. Global 20s Proteasome Sales Market Share by Manufacturer in 2020
Figure 25. Global 20s Proteasome Revenue Market Share by Manufacturer in 2020
Figure 26. 20s Proteasome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. Top 3 20s Proteasome Manufacturer (Revenue) Market Share in 2020
Figure 28. Top 6 20s Proteasome Manufacturer (Revenue) Market Share in 2020
Figure 29. Global 20s Proteasome Sales Market Share by Region (2016-2026)
Figure 30. Global 20s Proteasome Revenue Market Share by Region (2016-2026)
Figure 31. North America 20s Proteasome Revenue (2016-2026) & (USD Million)
Figure 32. Europe 20s Proteasome Revenue (2016-2026) & (USD Million)
Figure 33. Asia-Pacific 20s Proteasome Revenue (2016-2026) & (USD Million)
Figure 34. South America 20s Proteasome Revenue (2016-2026) & (USD Million)
Figure 35. Middle East & Africa 20s Proteasome Revenue (2016-2026) & (USD Million)
Figure 36. Global 20s Proteasome Sales Market Share by Type (2016-2026)
Figure 37. Global 20s Proteasome Revenue Market Share by Type (2016-2026)
Figure 38. Global 20s Proteasome Price by Type (2016-2026) & (USD/Pcs)
Figure 39. Global 20s Proteasome Sales Market Share by Application (2016-2026)
Figure 40. Global 20s Proteasome Revenue Market Share by Application (2016-2026)
Figure 41. Global 20s Proteasome Price by Application (2016-2026) & (USD/Pcs)
Figure 42. North America 20s Proteasome Sales Market Share by Type (2016-2026)
Figure 43. North America 20s Proteasome Sales Market Share by Application (2016-2026)
Figure 44. North America 20s Proteasome Sales Market Share by Country (2016-2026)
Figure 45. North America 20s Proteasome Revenue Market Share by Country (2016-2026)
Figure 46. United States 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe 20s Proteasome Sales Market Share by Type (2016-2026)
Figure 50. Europe 20s Proteasome Sales Market Share by Application (2016-2026)
Figure 51. Europe 20s Proteasome Sales Market Share by Country (2016-2026)
Figure 52. Europe 20s Proteasome Revenue Market Share by Country (2016-2026)
Figure 53. Germany 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific 20s Proteasome Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific 20s Proteasome Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific 20s Proteasome Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific 20s Proteasome Revenue Market Share by Region (2016-2026)
Figure 62. China 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Korea 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America 20s Proteasome Sales Market Share by Type (2016-2026)
Figure 69. South America 20s Proteasome Sales Market Share by Application (2016-2026)
Figure 70. South America 20s Proteasome Sales Market Share by Country (2016-2026)
Figure 71. South America 20s Proteasome Revenue Market Share by Country (2016-2026)
Figure 72. Brazil 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East & Africa 20s Proteasome Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa 20s Proteasome Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa 20s Proteasome Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa 20s Proteasome Revenue Market Share by Country (2016-2026)
Figure 78. Turkey 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Egypt 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South Africa 20s Proteasome Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
世界の上皮性卵巣がん治療市場 2021：企業別、地域別、種類・用途別 The Epithelial Ovarian Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…- 世界の卵巣がん治療薬市場 2021：企業別、地域別、種類・用途別 The Ovarian Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の転移性卵巣がん治療薬市場 2021：企業別、地域別、種類・用途別 The Metastatic Ovarian Cancer Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界のがんバイオセラピー市場 2021：企業別、地域別、種類・用途別 The Cancer Biotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
- 世界の前立腺がん市場 2021：企業別、地域別、種類・用途別 The Prostate Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…